Renalytix AI (GB:RENX) has released an update.
Renalytix AI has announced the issuance of new shares to repay $1.06 million of its convertible bond principal, reducing the remaining debt to $11.66 million. The company will release over 11 million new ordinary shares and expects these to be admitted to trading on the AIM market by July 17, 2024. Following the admission, Renalytix AI’s total issued share capital will equate to 165,925,513 ordinary shares with corresponding voting rights.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.
